Abstract
Multi-drug-resistant tuberculosis (MDR-TB) is a form of tuberculosis (TB) infection which is resistant to treatment with at least two of the most powerful first-line anti-TB drugs, namely isoniazid and rifampicin. Globally, MDR-TB caused an estimated 480 000 new TB cases and 250 000 deaths in 2015 and accounted for 3.3% of all new TB cases worldwide.1 MDR-TB, or rifampicin-resistant TB, causes 3.9% of new TB cases and 21% of previously treated TB cases, and most MDR-TB cases occur in South America, southern Africa, India, China, and the former Soviet Union.1
Highlights
We are aware that MDR-TB is man-made due to the following factors: a
To reduce the incidence of MDR-TB, it is imperative that TB is treated correctly the first time
It is these man-made factors that result in the emergence of MDR-TB
Summary
We are aware that MDR-TB is man-made due to the following factors: a. Poor patient adherence to complete the full course of TB Healthcare providers prescribing the wrong treatment, wrong dose, or length of time for TB drugs c.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
